Back to results
US 10,273,211 B2Granted
Metabolites of N-{4-([6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
AssigneeExelixis, Inc.
InventorsDana T. Aftab, Sriram Naganathan, Wei Xu, Steven Lacy, Linh Nguyen
Life of this patent
Estimating the term…
Abstract
The invention relates to metabolites of cabozantinib (I) as well as uses thereof.
Claims2
A pharmaceutical composition comprising a compound selected from the group consisting of:
- or a pharmaceutically acceptable salt thereof;
- and at least one pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.